Balaxi Pharmaceuticals Ltd 30 May 2024 12:00 AM
Balaxi Pharmaceuticals consolidated net profit rises 34.94% in the March 2024 quarter,
Net profit of Balaxi Pharmaceuticals rose 34.94% to Rs 10.93 crore in the quarter ended March 2024 as against Rs 8.10 crore during the previous quarter ended March 2023. Sales declined 25.84% to Rs 59.83 crore in the quarter ended March 2024 as against Rs 80.68 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 2.39 crore in the year ended March 2024 as against net profit of Rs 45.96 crore during the previous year ended March 2023. Sales declined 28.28% to Rs 241.29 crore in the year ended March 2024 as against Rs 336.43 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales59.8380.68 -26 241.29336.43 -28 OPM %22.5115.79 -19.3716.80 - PBDT11.0712.26 -10 42.4058.67 -28 PBT10.4011.07 -6 40.3156.92 -29 NP10.938.10 35 -2.3945.96 PL Powered by Capital Market - Live News
Balaxi Pharmaceuticals Ltd 24 May 2024 12:00 AM
Balaxi Pharmaceuticals to conduct board meeting,
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2024.Powered by Capital Market - Live News
Balaxi Pharmaceuticals Ltd 10 Feb 2024 12:00 AM
Balaxi Pharmaceuticals announces board meeting date,
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 February 2024.Powered by Capital Market - Live News
Balaxi Pharmaceuticals Ltd 09 Feb 2024 12:00 AM
Balaxi Pharmaceuticals consolidated net profit rises 65.13% in the December 2023 quarter,
Net profit of Balaxi Pharmaceuticals rose 65.13% to Rs 13.59 crore in the quarter ended December 2023 as against Rs 8.23 crore during the previous quarter ended December 2022. Sales declined 29.79% to Rs 60.79 crore in the quarter ended December 2023 as against Rs 86.58 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales60.7986.58 -30 OPM %22.4717.67 - PBDT13.1110.71 22 PBT12.6310.53 20 NP13.598.23 65 Powered by Capital Market - Live News
Balaxi Pharmaceuticals Ltd 02 Nov 2023 12:00 AM
Balaxi Pharmaceuticals consolidated net profit declines 6.84% in the September 2023 quarter,
Net profit of Balaxi Pharmaceuticals declined 6.84% to Rs 14.43 crore in the quarter ended September 2023 as against Rs 15.49 crore during the previous quarter ended September 2022. Sales declined 36.65% to Rs 54.72 crore in the quarter ended September 2023 as against Rs 86.38 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales54.7286.38 -37 OPM %19.6617.08 - PBDT10.6718.87 -43 PBT10.0118.68 -46 NP14.4315.49 -7 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now